莫桑比克贝拉市单剂量奈韦拉平治疗后，通过母乳传播耐奈韦拉平的 HIV-1 型病毒给婴儿。
Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.
机构信息
University of Washington Health Alliance International.
University of Washington Seattle Children's Research Institute, Seattle, Washington;
出版信息
J Infect Dis. 2014 Aug 15;210(4):641-5. doi: 10.1093/infdis/jiu130. Epub 2014 Mar 4.
Abstract
Acquisition of nevirapine (NVP)-resistant human immunodeficiency virus type 1 (HIV-1) by breast-feeding infants after receipt of single-dose NVP to prevent mother-to-child transmission is not well defined. A prospective observational study of 307 infants evaluated the rate of breast milk transmission of NVP-resistant HIV and the concentrations of mutants over time. NVP resistance was detected in 9 of 24 infants (37.5%; 95% confidence interval, 18.8%-59.4%) infected via breast milk. Eight had a pure mutant HIV population at the time infection was first detected, and majority mutant populations persisted in all 6 infants with follow-up specimens. Infection of breast-feeding infants with NVP-resistant HIV resulted in mutants persisting as the dominant virus, which may indefinitely compromise treatment with NVP-based antiretroviral regimens.
摘要
通过单次接受奈韦拉平（NVP）预防母婴传播而获得的 NVP 耐药性人类免疫缺陷病毒 1 型（HIV-1）的母乳喂养婴儿的获得情况尚未明确。一项对 307 名婴儿进行的前瞻性观察性研究评估了 NVP 耐药性 HIV 通过母乳传播的速度以及突变体随时间的浓度。通过母乳喂养感染的 24 名婴儿中有 9 名（37.5%；95%置信区间，18.8%-59.4%）检测到 NVP 耐药。其中 8 人在首次检测到感染时就存在纯突变 HIV 种群，在所有 6 名具有随访标本的婴儿中，多数突变种群持续存在。用 NVP 耐药性 HIV 感染母乳喂养婴儿会导致突变体持续成为主要病毒，这可能会无限期地影响基于 NVP 的抗逆转录病毒方案的治疗。
相似文献
1
Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.莫桑比克贝拉市单剂量奈韦拉平治疗后，通过母乳传播耐奈韦拉平的 HIV-1 型病毒给婴儿。
J Infect Dis. 2014 Aug 15;210(4):641-5. doi: 10.1093/infdis/jiu130. Epub 2014 Mar 4.
2
Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.奈韦拉平耐药性与母乳中HIV传播：C亚型HIV感染婴儿单剂量和延长剂量奈韦拉平预防的效果
PLoS One. 2009;4(1):e4096. doi: 10.1371/journal.pone.0004096. Epub 2009 Jan 1.
3
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.单次奈韦拉平预防给药后母乳中奈韦拉平耐药的 HIV-1 变异体的克隆扩增和母婴传播。
Retrovirology. 2013 Aug 14;10:88. doi: 10.1186/1742-4690-10-88.
4
Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.在接受奈韦拉平延长预防方案以预防母婴HIV传播但治疗失败的婴儿中，对奈韦拉平耐药病毒的清除较慢。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):823-9. doi: 10.1089/aid.2010.0346. Epub 2011 Feb 25.
5
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.与 7 天疗程相比，在预防 HIV 母婴传播的单剂量产后奈韦拉平方案中，21 天抗逆转录病毒方案对奈韦拉平耐药性的抑制作用更强。
Clin Infect Dis. 2013 Apr;56(7):1044-51. doi: 10.1093/cid/cis1219. Epub 2013 Jan 8.
6
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.延长抗逆转录病毒预防措施以减少母乳中HIV-1的传播。
N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4.
7
Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.单次奈韦拉平给药后母乳中奈韦拉平耐药性的出现和持续存在。
AIDS. 2010 Feb 20;24(4):557-61. doi: 10.1097/QAD.0b013e3283346e60.
8
Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.在乌干达感染1型艾滋病毒的妇女接受奈韦拉平单剂量预防后，其母乳和血浆中的1型艾滋病毒微小耐药性变体
Antivir Ther. 2011;16(1):109-13. doi: 10.3851/IMP1698.
9
10
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.产后单剂量替诺福韦酯/恩曲他滨不能预防在产前接受齐多夫定及产时接受单剂量奈韦拉平以预防母婴HIV-1传播的女性中出现非核苷类逆转录酶抑制剂耐药。
J Med Virol. 2015 Oct;87(10):1662-7. doi: 10.1002/jmv.24220. Epub 2015 May 4.
引用本文的文献
1
HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.莫桑比克的HIV-1抗逆转录病毒药物耐药性：一项系统评价与荟萃分析
Viruses. 2024 Nov 21;16(12):1808. doi: 10.3390/v16121808.
2
Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.莫桑比克马普托市一项母婴预防项目中接受治疗的感染艾滋病毒的产前和产后妇女的奈韦拉平头发和血浆浓度以及HIV-1病毒抑制情况。
PLoS One. 2022 Feb 10;17(2):e0261522. doi: 10.1371/journal.pone.0261522. eCollection 2022.
3
Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.一种用于定量母乳中多替拉韦的新型液相色谱-质谱法的验证及临床应用
Bioanalysis. 2018 Dec;10(23):1933-1945. doi: 10.4155/bio-2018-0085. Epub 2018 Nov 19.
4
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.莫桑比克利用下一代测序技术分析孕妇的 HIV 耐药模式。
PLoS One. 2018 May 9;13(5):e0196451. doi: 10.1371/journal.pone.0196451. eCollection 2018.
5
Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission.南非儿童使用奈韦拉平预防母婴传播后HIV耐药性的持续情况。
AIDS. 2017 May 15;31(8):1143-1148. doi: 10.1097/QAD.0000000000001446.
6
Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique.在莫桑比克马普托参与预防母婴传播艾滋病毒-1项目的儿童中奈韦拉平耐药性的发展情况
PLoS One. 2015 Jul 10;10(7):e0131994. doi: 10.1371/journal.pone.0131994. eCollection 2015.
7
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.产后单剂量替诺福韦酯/恩曲他滨不能预防在产前接受齐多夫定及产时接受单剂量奈韦拉平以预防母婴HIV-1传播的女性中出现非核苷类逆转录酶抑制剂耐药。
J Med Virol. 2015 Oct;87(10):1662-7. doi: 10.1002/jmv.24220. Epub 2015 May 4.
8
Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study.依非韦伦的母乳药代动力学及母婴配对基因定义亚组中母乳喂养婴儿的暴露情况：一项观察性研究。
Clin Infect Dis. 2015 Aug 1;61(3):453-63. doi: 10.1093/cid/civ317. Epub 2015 Apr 16.
本文引用的文献
1
Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission.单剂量奈韦拉平联合或不联合齐多夫定预防母婴传播后母乳中耐奈韦拉平的HIV-1 DNA
J Pediatric Infect Dis Soc. 2012 Sep;1(3):244-9. doi: 10.1093/jpids/pis065. Epub 2012 Jul 3.
2
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.资源有限环境下抗逆转录病毒治疗推出后治疗初治 HIV 感染者的抗逆转录病毒耐药全球趋势：一项全球协作研究和荟萃回归分析。
Lancet. 2012 Oct 6;380(9849):1250-8. doi: 10.1016/S0140-6736(12)61038-1. Epub 2012 Jul 23.
3
HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.在一项用于预防母婴传播的三联抗逆转录病毒预防的单臂试验中，感染 HIV 的母亲所生的母乳喂养婴儿中 HIV-1 耐药性的出现：一项二次分析。
PLoS Med. 2011 Mar;8(3):e1000430. doi: 10.1371/journal.pmed.1000430. Epub 2011 Mar 29.
4
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.基于蛋白酶抑制剂的病毒抑制后，暴露于 HIV 感染的儿童中重复使用奈韦拉平：一项随机对照试验。
JAMA. 2010 Sep 8;304(10):1082-90. doi: 10.1001/jama.2010.1278.
5
Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.单剂量奈韦拉平治疗婴儿时，HIV-1 感染时间与奈韦拉平耐药的关系。
Clin Infect Dis. 2010 May 15;50(10):1405-14. doi: 10.1086/652151.
6
Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.奈韦拉平耐药性与母乳中HIV传播：C亚型HIV感染婴儿单剂量和延长剂量奈韦拉平预防的效果
PLoS One. 2009;4(1):e4096. doi: 10.1371/journal.pone.0004096. Epub 2009 Jan 1.
7
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.对乌干达婴儿进行奈韦拉平（NVP）耐药性分析，这些婴儿尽管接受了单剂量（SD）奈韦拉平或6周龄前每日服用奈韦拉平加单剂量奈韦拉平以预防HIV垂直传播，但仍感染了HIV。
J Infect Dis. 2008 Oct 1;198(7):1075-82. doi: 10.1086/591503.
8
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.暴露于单剂量奈韦拉平的女性中耐药HIV-1 C型在母乳中的排出情况
J Infect Dis. 2005 Oct 1;192(7):1260-4. doi: 10.1086/444424. Epub 2005 Aug 23.
9
Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection.原发性HIV感染后未经治疗时耐药性突变的长期留存及疾病的快速进展。
AIDS. 2003 May 23;17(8):1256-8. doi: 10.1097/00002030-200305230-00020.
10
Antiretroviral-drug resistance among patients recently infected with HIV.近期感染艾滋病毒患者中的抗逆转录病毒药物耐药性。
N Engl J Med. 2002 Aug 8;347(6):385-94. doi: 10.1056/NEJMoa013552.
Zotero 插件